(Q48686857)

14 February 2018

title

A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial function (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

21 October 2022

3

C D Marsden

1 reference

14 February 2018

M. J. Walker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651082

21 October 2022

P. Jenner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651082

21 October 2022

C. D. Marsden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651082

21 October 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

14 February 2018

25 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1651082

full work available at URL

21 October 2022

https://api.elsevier.com/content/article/PII:0006295291900538?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

https://api.elsevier.com/content/article/PII:0006295291900538?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

21 October 2022

published in

Biochemical Pharmacology

1 reference

14 February 2018

volume

42

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

page(s)

913-919

1 reference

14 February 2018

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion

21 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

MPP+-induced pathophysiology demonstrates advantages of neurotoxicology studies in brain slices

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Preparation and properties of mitochondria derived from synaptosomes

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Protein measurement with the Folin phenol reagent

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver.

21 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Astrocytes as a primary locus for the conversion MPTP into MPP+

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+.

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Chemically induced Parkinson's disease. II: Intermediates in the oxidation and reduction reactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains.

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90053-8

21 October 2022

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018